We have been made aware of a situation in which employees have received letters from MetLife informing them that their critical illness insurance has been cancelled. Please note that these letters were sent out in error. Learn more.
Needs Review Not Apprvd
DEA reschedules Hydrocodone Combination Products (HCP) to a Class II Controlled Substance
The U.S. Drug Enforcement Administration (DEA) has issued a final rule rescheduling hydrocodone combination products (HCPs) from schedule III to the more-restrictive schedule II of the Controlled Substances Act. HCPs are drugs that contain both hydrocodone, and specified amounts of other substances, such as acetaminophen or aspirin.
The new rules mean that medications such as Vicodin, Norco, Lortab and other generic versions will be subject to the same prescribing rules as painkillers like codeine and oxycodone. Patients will be limited to one prescription (no more than a 90-day supply of medication) and will have to see a health care professional to get a refill. In many states, prescribing authority will be limited to physicians, not nurses or physician assistants. Additionally, the provider will no longer be able to phone the prescription into a pharmacy.
This new rule is effective October 6, 2014. If you have further questions on how this rule will affect you, please contact your healthcare professional.
April Retiree Benefit Mailing Date
Retirees: April 25 benefits will be deposited and checks will be mailed today, April 25.
Read MoreSeminar: Supplemental Annuity Plan & Deferred Compensation Plan
Join us May 10, 2024 for a Supplemental Annuity Plan & Deferred Compensation Plan Seminar.
Read MoreAlaskaCare Retiree Town Hall-April
Please join us for a Town Hall event April 18, 2024, 10 a.m. Alaska Time.
Read More